The relative mRNA expression levels of BCR/ABL and JAK2 between the LPCs and other cell fractions from the patients with de novo Ph+ALL (N = 6) were further analyzed using qRT-PCR assays. This evidence concerns the gene BCR and acute lymphoblastic leukemia.